3) Medical Countermeasures Initiative
Abstract
The MCMI will integrate the regulatory science and manufacturing technologies and processes developed into the Advanced Development and Manufacturing Facility (MCM-ADM) to support establishment of platform capabilities as enablers of the advanced development of CBDP medical countermeasure products. These initiatives will lead to the development of multi-use platforms that have the potential to accelerate medical product development and/or regulatory approval as well as reduce overall development costs.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2021
- Source ID
- 830d4bca1023b6c6fd9986a72d4dbb0b